Results 6,201-6,220 of 8,016 for speaker:Peter Burke

Written Answers — Department of Finance: Tax Data (23 May 2018)

Peter Burke: 87. To ask the Minister for Finance the estimated amount of tax that would be due on the import of vehicles (details supplied); and if he will make a statement on the matter. [22788/18]

Written Answers — Department of Public Expenditure and Reform: Community Employment Schemes Supervisors (23 May 2018)

Peter Burke: 90. To ask the Minister for Public Expenditure and Reform the number of times the community sector high level forum or working group has met; if it has considered the issue of pensions for community employment scheme supervisors in recent months; if it has identified a pathway to an appropriate solution regarding pensions for supervisors; if there is a timeline in place for the review group...

Written Answers — Department of Finance: Mortgage Schemes (22 May 2018)

Peter Burke: 132. To ask the Minister for Finance the status of his efforts to have a bank's (details supplied) split mortgages reclassified as performing loans by the single supervisory mechanism; and if he will make a statement on the matter. [22035/18]

Written Answers — Department of Health: Hospital Appointments Status (22 May 2018)

Peter Burke: 385. To ask the Minister for Health if an appointment for a person (details supplied) will be expedited. [22265/18]

Written Answers — Department of Health: HSE Properties (22 May 2018)

Peter Burke: 421. To ask the Minister for Health the status of the proposed development of the new car park at a centre (details supplied); when the works will take place; and if he will make a statement on the matter. [22545/18]

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: I thank the witnesses for attending. I will focus on the contract with the laboratories and my understanding of how that contract operates. Will Mr. Gleeson take me through the safeguards or risk procedures in place in the event that one of the laboratories is found not to be performing or limitations are found? How would the organisation identify that and how it would come to light?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: In any basic study of statistics, if something is being described as a false negative, it is an indication of a limitation in the test. If two or more false negatives are produced for one woman and it transpires that some of the slides are perverse in terms of either the rate of cells or the high-grade cells that were present or the woman had cancer at that time, would that not ring alarm...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: This is a very simple mathematical formula.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: I am asking for a brief outline of the statistics.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: This is a central point. We hear the term "false negatives" being thrown around but there is also incompetence, pure and simple, where a slide has not been read correctly. As Vicky Phelan stated yesterday, given that cancer was prevalent in one of her slides, one could conclude the slide was not even read. That is how concerned she was. How are we getting on top of the limitation in...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: We do not need an international expert to tell us that false negatives have arisen for a number of different women. The laws of probability would suggest the chances of this happening are negligible or zero. I cannot get my head around that.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: Just to clarify, we are exclusively relying upon these laboratories. At that time, we did not do any independent checking. Once the laboratories were accredited and quality assured, that was it from the HSE's point of view. Is that correct?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: I still find it difficult to reconcile in my own mind that we have individual women with a number of false negatives. If the slide is that perverse, and it was the second slide in Ms Phelan's case as was detailed, in terms of how high grade it was or even how the prevalence of cancer was missed, is Mr. Gleeson able to see a variation between the laboratories? Is he able to answer that...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: Mr. Gleeson has not seen anything that would suggest-----

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: In terms of the two-way exchange of information from CervicalCheck and the National Cancer Registry that was not present, was that not a fundamental basic thing one would think should happen, that they should be reconciled and anyone on the National Cancer Registry should immediately be reverted back to the CervicalCheck register to see whether they had a smear test?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: When someone is diagnosed, we obviously have to revert back to see whether the woman was screened and how accurate was the screening programme. That was not evident.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: Did the HSE try?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: Is that not present in other programmes, such as BreastCheck or BowelScreen? I know there are different demographics, but we were told here there is a two-way exchange of information with those independent programmes. If so, how was it possible in them and not in CervicalCheck?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: Is it the case? "May well be" is not good enough. I want to be very clear on this.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Peter Burke: I want to be very clear on this.